Discontinuation of Immune-oncology Combinations Due to Immune-related Adverse Events in Patients with Advanced Renal Cancers.
ANTICANCER RESEARCH(2024)
关键词
Renal cell carcinoma,immune-oncology drug,immune related adverse event,retreatment,discontinuation
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要